Antihypertensive Dose of Ramipril
For hypertension, start ramipril at 2.5 mg once daily and titrate to a usual maintenance range of 2.5-20 mg daily, administered as a single dose or divided twice daily if the antihypertensive effect diminishes toward the end of the dosing interval 1.
Initial Dosing
The FDA-approved starting dose for hypertension in patients not receiving a diuretic is 2.5 mg once daily 1. This recommendation is supported by dose-response studies demonstrating that 2.5 mg represents the minimum effective dose, with significant blood pressure reductions compared to placebo 2.
- Lower starting dose (1.25 mg once daily): Consider in patients with renal impairment (creatinine clearance <40 mL/min), volume depletion, or those at risk for hypotension 1
- Standard starting dose (2.5 mg once daily): Appropriate for most patients with uncomplicated hypertension 1
Dose Titration and Maintenance
Titrate according to blood pressure response, with the usual maintenance range being 2.5-20 mg per day 1. Clinical trials demonstrate a clear dose-response relationship:
- 2.5 mg once daily: Effective in 52% of patients 3
- 5 mg once daily: Effective in 70% of patients 3
- 10 mg once daily: Effective in 78% of patients 3
In real-world practice, most patients achieve control with relatively low doses—41% required only 2.5 mg and 81% required ≤5 mg once daily 4.
Dosing Frequency Considerations
If the antihypertensive effect diminishes toward the end of the 24-hour dosing interval, consider either increasing the total daily dose or switching to twice-daily administration 1. This is clinically important because:
- Peak blood pressure reductions occur 3-6 hours after dosing 1
- Trough effects represent approximately 50-60% of peak response 1
- Divided (twice daily) dosing has proven superior to once-daily dosing in some patients 1
Bedtime dosing may be more effective than morning dosing for controlling nocturnal blood pressure, with one study showing the proportion of controlled patients increased from 43% to 65% (p=0.019) when ramipril was administered at bedtime rather than on awakening 5. This is particularly relevant since nighttime blood pressure is a stronger predictor of cardiovascular risk.
Special Populations
Renal Impairment
- Creatinine clearance >40 mL/min: Use usual dosing regimen 1
- Creatinine clearance ≤40 mL/min: Start with 1.25 mg once daily; maximum dose 5 mg daily 1
Post-Myocardial Infarction with Heart Failure
While not specifically for hypertension, the dosing differs significantly:
- Start at 2.5 mg twice daily (or 1.25 mg twice daily if hypotensive)
- Titrate toward target of 5 mg twice daily over several weeks 1
Combination Therapy
If blood pressure is not controlled with ramipril alone, add a diuretic rather than pushing to maximum ramipril doses 1. Current guidelines support combination therapy as initial treatment for most patients with confirmed hypertension (BP ≥140/90 mmHg), preferably using single-pill combinations of a RAS blocker with either a dihydropyridine calcium channel blocker or thiazide diuretic 6.
Clinical Context from Guidelines
The 2013 ACC/AHA STEMI guidelines provide specific post-MI dosing: ramipril 2.5 mg twice daily initially, titrating to 5 mg twice daily as tolerated 7. The 2020 ISH guidelines position ACE inhibitors/ARBs as first-line therapy for non-Black patients, starting at low doses and increasing to full doses before adding additional agents 8.
Common Pitfalls
- Underdosing: Many patients remain on 2.5 mg when they could benefit from higher doses up to 10-20 mg daily
- Ignoring end-of-dose effect: If blood pressure rises before the next dose, switch to twice-daily dosing rather than abandoning the medication
- Not adjusting for renal function: Failure to reduce initial dose in renal impairment increases hypotension risk
- Inadequate monitoring: Blood pressure should be reassessed 1-2 weeks after dose changes to guide titration